News – Page 771 – Endpoints News

News briefing: Incyte bankrolls an early-stage myelofibrosis pair-up with Jakafi; InnoCare gets Chinese approval for ...

5 years ago

After a ‘breakthrough’ beginning to 2020, little Aprea gets crushed by a PhIII failure

5 years ago

With pipeline setbacks mounting, United snares priority voucher for inhaled formulation of PAH med Tyvaso

5 years ago

Pharma heavyweight Pfizer stepping into the prostate cancer ring with AbbVie after inking a $4.2B alliance with ...

5 years ago

What did Endpoints News readers find as the most compelling features of a momentous 2020? Here are the top 10

5 years ago

Groups seek clarity on interchangeability in BsUFA III

5 years ago

Covid-19 roundup: Sinovac pulls back from a promised PhIII data reveal, raising questions about efficacy

5 years ago

A federal judge blocks Donald Trump's 'most favored nation' drug pricing plan as the lease runs out on the White ...

5 years ago

Vivek Ramaswamy's 'vant' brainchildren keep bearing fruit with Urovant's FDA nod for incontinence med vibegron

5 years ago

Altimmune shares slide as the FDA flashes a red light for the IND work on their intranasal Covid-19 vaccine

5 years ago

News briefing: Merck buys into A2's T cell therapy platform; Small Soligenix reports PhIII fail in head and neck ...

5 years ago

Amgen hands off rights to leprosy, tuberculosis med picked up as part of $13.4B Otezla deal

5 years ago

Cytokinetics may walk a lonely road to market with tarnished heart med omecamtiv after last partner bows out

5 years ago

Riding on rosy estimates of Zolgensma sales, RegenxBio sells part of its royalty for $200M

5 years ago

Supernus touts winning data in adult ADHD as it looks to make its case with the FDA — again — for pediatric use

5 years ago

After multiple setbacks, Bristol Myers scuttles Opdivo program for brain tumor patients after failing to prolong ...

5 years ago

Twist Bioscience plots its 'factory of the future' in Oregon, seeks to expand synthetic DNA client base

5 years ago

Alnylam bids adieu to 2020 — and hello to a slate of new execs; Novavax taps Rick Crowley as COO

5 years ago

The final hours and days are ticking away on a $6B bet as deadline looms on a suspenseful FDA decision

5 years ago

Nektar sells off royalties on its 2 approved drugs for $150M in cash, redoubling focus on I-O candidates

5 years ago

Warp Speed bets $356M to mass manufacture a Merck drug for severe Covid-19

5 years ago

Trump pardons Chris Collins, former congressman imprisoned for biotech insider trading scandal

5 years ago

Covid-19 roundup: US and Pfizer strike deal for 100M more doses; NIH and partners cut critically ill patients out of ...

5 years ago

FDA slaps a hold on Voyager's lead gene therapy over 'MRI abnormalities'

5 years ago

First page Previous page 768 769 770771772 773 774 Next page Last page